MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1811-01-01

Employees: -

Market Cap: -

Website: http://www.massgeneral.org/international

Clinical Trials

Study of Home-Based Resistance and Strength Training in HIV-Infected Women

Not Applicable

Completed

Conditions: HIV Infections

First Posted Date: 2005-05-20

Last Posted Date: 2010-04-14

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 40

Registration Number: NCT00111332

Locations: 🇺🇸
Mass General Hospital, Boston, Massachusetts, United States

Treatment Study Investigating New Cognitive Behavioral Therapy Treatment Manual for Body Dysmorphic Disorder

Not Applicable

Completed

Conditions: Body Dysmorphic Disorder
Somatoform Disorders

Interventions: Behavioral: Cognitive behavioral therapy (CBT)

First Posted Date: 2005-03-22

Last Posted Date: 2012-01-05

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 36

Registration Number: NCT00106223

Locations: 🇺🇸
Body Image Program, Butler Hospital, Providence, Rhode Island, United States
🇺🇸
BDD Clinic, Massachusetts General Hospital, Charlestown, Massachusetts, United States

Proton Beam Radiation Therapy in Treating Young Patients Who Have Undergone Biopsy or Surgery for Medulloblastoma or Pineoblastoma

Not Applicable

Completed

Conditions: Brain and Central Nervous System Tumors
Long-term Effects Secondary to Cancer Therapy in Children

Interventions: Radiation: radiation therapy

First Posted Date: 2005-03-16

Last Posted Date: 2021-12-28

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 59

Registration Number: NCT00105560

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Physiologic Growth Hormone Effects in HIV Lipodystrophy

Not Applicable

Completed

Conditions: AIDS
HIV Infections

Interventions: Drug: placebo
Drug: recombinant human growth hormone

First Posted Date: 2005-01-05

Last Posted Date: 2010-07-27

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 56

Registration Number: NCT00100698

Locations: 🇺🇸
MGH, Boston, Massachusetts, United States

Imuran (Azathioprine) Dose-Ranging Study in Crohn's Disease

Phase 3

Terminated

Conditions: Crohn's Disease

Interventions: Drug: azathioprine

First Posted Date: 2004-12-06

Last Posted Date: 2014-02-21

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 31

Registration Number: NCT00098111

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Neoadjuvant Chemotherapy Using Doxorubicin and Paclitaxel in Treating Women With Large Breast Cancer

Phase 2

Completed

Conditions: Breast Cancer

Interventions: Other: Doxorubicin followed by Paclitaxel
Other: Paclitaxel followed by Doxorubicin

First Posted Date: 2004-11-09

Last Posted Date: 2017-04-10

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 62

Registration Number: NCT00096291

Locations: 🇺🇸
Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States
🇺🇸
Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston, Massachusetts, United States

Gefitinib in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer That Did Not Respond to Iodine Therapy

Phase 2

Completed

Conditions: Head and Neck Cancer

Interventions: Drug: Gefitinib

First Posted Date: 2004-11-09

Last Posted Date: 2017-05-31

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 27

Registration Number: NCT00095836

Locations: 🇺🇸
Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States
🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States

Androgen Effects in HIV-infected Women

Not Applicable

Completed

Conditions: HIV Infection

Interventions: Drug: 1 Transdermal Testosterone (Patch)
Drug: 2 Placebo Patch

First Posted Date: 2004-11-02

Last Posted Date: 2010-04-14

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 25

Registration Number: NCT00095212

Locations: 🇺🇸
Mass General Hospital, Boston, Massachusetts, United States

Optimizing the Effectiveness of Selective Serotonin Reuptake Inhibitors (SSRIs) in Treatment-Resistant Depression

Phase 2

Completed

Conditions: Depression

Interventions: Drug: Placebo
Drug: S-adenosyl methione (SAMe)

First Posted Date: 2004-10-08

Last Posted Date: 2014-10-13

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 73

Registration Number: NCT00093847

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Bone Loss in Women With Anorexia Nervosa

Phase 2

Completed

Conditions: Anorexia Nervosa

Interventions: Drug: Actonel (risedronate)
Drug: Testosterone
Drug: Placebo testosterone
Drug: Placebo Actonel (risedronate)

First Posted Date: 2004-08-17

Last Posted Date: 2020-09-02

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 77

Registration Number: NCT00089843

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy